What the analyst said
HSBC analyst Yuqian Ding raised the price target on XPeng (NYSE: XPEV) to $29.60 (from $27.40) while maintaining a Buy rating.
“We continue to use a DCF to value the stock. With our refreshed 2025-27 earnings estimates, we arrive new target price for US-listed share of USD29.60 (from USD27.40), implying c45% upside, and we maintain our Buy rating. We have a HKD115.00 TP on the H-share (9868 HK, CMP HKD80.45), from HKD107.00 previously, using an RMB/HKD FX rate of 1.10 (previously 1.06).”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
XPEV trades at $9.38. The 9 analysts who set a target in the last 3 months range from $10 to $20, with a median of $15. This $29.60 target is 97% above the median, the highest on the Street.
Since the note XPEV has moved −59% (from $22.75). The 12-month window closed on August 22, 2026.
Track record
This call✗ Not reached within 12 months: a year after the note XPEV closed at $11.15, 62% below the $29.60 target, and it moved the other way.
Firm track recordHSBC: 60% of its 30 targets at least a year old were reached within 12 months (#29 of 29 firms). Accuracy ranking →
HSBC on XPeng
HSBC price targets on XPeng
3 calls from August 22, 2025 to November 20, 2026. The target went from $29.60 to $10.10 (−66%). The rating moved from Buy to Hold.
- November 20, 2026Downgraded to Hold, target cut from $27.70 (−64%)Hold$10.10
- January 20, 2026Target cut from $29.60 (−6%)Buy$27.70
- August 22, 2025 This noteEarliest call shownBuy$29.60




